Alain S. Herrera
Londrina, PR, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Proinflammatory circulating markers: new players for evaluating asymptomatic acute cardiovascular toxicity in breast cancer treatment.
Journal: Journal of chemotherapy (Florence, Italy)
Published: January 22, 2021
Short infusion of paclitaxel imbalances plasmatic lipid metabolism and correlates with cardiac markers of acute damage in patients with breast cancer.
Journal: Cancer chemotherapy and pharmacology
Published: May 17, 2017
Ribociclib for HR-Positive, Advanced Breast Cancer.
Journal: The New England journal of medicine
Published: January 20, 2017
PGC-1β regulates HER2-overexpressing breast cancer cells proliferation by metabolic and redox pathways.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: August 10, 2015
Can Breast Tumors Affect the Oxidative Status of the Surrounding Environment? A Comparative Analysis among Cancerous Breast, Mammary Adjacent Tissue, and Plasma.
Journal: Oxidative medicine and cellular longevity
Published: May 22, 2015
Trastuzumab-based chemotherapy modulates systemic redox homeostasis in women with HER2-positive breast cancer.
Journal: International immunopharmacology
Published: January 09, 2015
Clinical insights from adiponectin analysis in breast cancer patients reveal its anti-inflammatory properties in non-obese women.
Journal: Molecular and cellular endocrinology
Published: September 03, 2013
Decreased oxidant profile and increased antioxidant capacity in naturally postmenopausal women.
Journal: Age (Dordrecht, Netherlands)
Published: March 14, 2012
Molecular subtype is determinant on inflammatory status and immunological profile from invasive breast cancer patients.
Journal: Cancer immunology, immunotherapy : CII
Published: March 07, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026